跳至主要内容
临床试验/ACTRN12606000486527
ACTRN12606000486527已完成未知

The effect of location of airflow measurement on the ability to assess Apnea Hypopnea Index (AHI) during Continuous Positive Airway Pressure (CPAP) therapy in patients with Obstructive Sleep Apnea (OSA) undergoing subtherapeutic CPAP and AutoCPAP therapy.

DiagnoseIT Pty Ltd, Sydney, NSW, Australia0 个研究点目标入组 34 人开始时间: 2006年11月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • Subjects must satisfy the following inclusion criteria:Previously diagnosed with moderate-severe obstructive sleep apnea (RDI>15)Compliant CPAP use for at least 3 months durationCompliance: CPAP use > 4 hours per night for at least 5 nights per week No significant problems with CPAP therapy such as mask/mouth leak or severe nasal congestion. English speaking.

排除标准

  • Other sleep disorders including:PLMD Untreated RLS >10 Central apnoeas/hr on diagnostic sleep studyNeurological disordersPsychiatric disordersSignificant medical complaint including:Severe cardiovascular disease Congestive heart failure Significant lung disease (e.g., chronic obstructive pulmonary disease) Daytime hypoxemia and respiratory failure from any cause Prominent nocturnal desaturation other than from OSA (e.g., obesity hypoventilation syndrome).

研究者

发起方
DiagnoseIT Pty Ltd, Sydney, NSW, Australia

相似试验